Fosmidomycin Sodium Salt (CAS 66508-37-0)

Fosmidomycin Sodium Salt, carrying the CAS number 66508-37-0, is a derivative of fosmidomycin, a phosphonic acid antibiotic that has been extensively utilized in biochemical research for its unique mode of action against the enzyme 1-deoxy-D-xylulose 5-phosphate (DXP) reductoisomerase. This enzyme is a key component in the non-mevalonate pathway of isoprenoid biosynthesis, which is crucial for the production of terpenoids and isoprenoids in various bacteria and plants. Fosmidomycin Sodium Salt inhibits DXP reductoisomerase by mimicking the natural substrate of the enzyme, thereby blocking the pathway and disrupting the synthesis of essential metabolites derived from isoprenoids. This specific inhibition has made it a valuable tool in the study of the non-mevalonate pathway, providing insights into a critical metabolic route that differs from the mevalonate pathway found in humans and other higher organisms. Researchers employ Fosmidomycin Sodium Salt to explore the fundamental aspects of this pathway, investigating its role in cellular metabolism and the potential effects of its disruption. Such studies are pivotal in understanding metabolic diversity and the evolutionary aspects of metabolic pathways. Additionally, the use of this chemical in research aids in examining how organisms adapt to the inhibition of crucial biosynthetic pathways and can shed light on potential targets for controlling harmful bacterial growth.